[ad_1]
Dublin –(Business Wire) – This “UAE Pharmaceutical Market, By Drug Type (Generic vs Branded Drugs), By Product Type (Prescription vs OTC), By Application, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027” report added to ResearchAndMarkets.com’s supply.
The UAE pharmaceutical market is expected to grow at an impressive rate during the forecast period 2023-2027. The market growth can be attributed to the expanding healthcare infrastructure in the country and the substantial investments by market players in the development of effective medicines. Furthermore, the rising incidence of chronic diseases such as diabetes, cardiovascular diseases, kidney diseases, and infectious diseases is expected to drive the growth of the UAE pharmaceutical market in the coming years.
The government of the United Arab Emirates is actively promoting the development of the pharmaceutical industry. Due to its future growth potential, export potential and medium to long term economic impact, the pharmaceutical industry is the target of initiatives such as Dubai Industrial Strategy 2030 and Abu Dhabi Vision 2030.
The country’s pharmaceutical needs are mainly met by imported pharmaceuticals and pharmaceuticals. By increasing investment in research and development of medicines and therapeutic products, the state is actively working to reduce the import of medicines and the production of related products in the future.
The government is building relationships with key international market players to strengthen its pharmaceutical production. With favorable funding, distribution channel plans, strategic planning and highly developed logistics infrastructure, the UAE pharmaceutical business is expected to grow over the next five years.
The country’s pharmaceutical industry is expanding due to rising incidences of chronic diseases, infectious diseases and lifestyle disorders. Chronic diseases such as cancer, neurological diseases, and cardiovascular diseases are driving the expansion of the market. Both male and female residents of the country were found to have 4,807 new cancer cases.
The increase in tourism, environmental factors, and the recent viral infection caused by COVID-19 have led to an increase in infectious diseases, which has helped to increase the demand for medicinal products. The government is also supporting the idea by increasing investment in the industry. Interrupted import routes have forced pharmaceutical companies to manufacture medicines in the country.
Main target audience:
Market research and consulting firm
Government agencies such as regulators and policy makers
Organizations, Forums and Alliances
The research helps answer several key questions that are important to industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., in addition to allowing them to develop investment strategies and capitalize on market opportunities.
Report Scope:
In this report, in addition to the industry trends detailed below, the UAE pharmaceutical market is segmented into the following categories:
UAE Pharmaceuticals Market, by Drug Type:
generic drug
Branded medicine
UAE Pharmaceuticals Market, By Product Type:
prescription
over-the-counter drugs
UAE Pharmaceutical Market, By Application:
cardiovascular
musculoskeletal
Oncology
Anti-infective
metabolic disorder
other
UAE Pharmaceutical Market, By Distribution Channel:
retail pharmacy
hospital pharmacy
electronic pharmacy
UAE Pharmaceuticals Market, By Region:
Dubai area
Sharjah Region
Abu Dhabi Region
Rest of UAE
Key topics covered:
1. Product overview
2. Research methodology
3. Executive Summary
4. The impact of COVID-19 on the UAE pharmaceutical market
5. Voice of the customer
6. UAE pharmaceutical market outlook
6.1.Market size and forecast
6.1.1. By value
6.2. Market Share and Forecast
6.2.1. By Drug Type (Generic vs Brand Name)
6.2.2. By Product Type (Prescription & OTC)
6.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-Infective, Metabolic Disorders, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Electronic Pharmacy)
6.2.5.By region
6.2.6. By Company (2021)
6.3. Product Market Map
7. UAE Generic Drug Market Outlook
7.1.Market size and forecast
7.1.1. By value
7.2. Market Share and Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Distribution Channel
8. UAE Branded Drug Market Outlook
8.1.Market size and forecast
8.1.1.by value
8.2. Market Share and Forecast
8.2.1.By product type
8.2.2. By Application
8.2.3. By Distribution Channel
9. Market dynamics
9.1.driver
9.2. Challenges
10. Market Trends and Developments
11. Policy and Regulatory Environment
12. Overview of the UAE economy
13. Competitive Landscape
14. Strategic Recommendations
mentioned company
Julphar Gulf Pharmaceutical Industries
Bayer Consumer Health
Lifepharma FZE
Neina Pharmaceuticals LLC
GlaxoSmithKline and Neopharma
Pfizer UAE
Johnson & Johnson Middle East FZ-LLC
For more information on this report, please visit https://www.researchandmarkets.com/r/c059hx
[ad_2]
Source link